Tirzepatide

Neuropeptide analogue of gastric inhibitory polypeptide

Tirzepatide is a gastric inhibitory polypeptide (GIP) analog and a GLP-1 receptor agonist. It is used as an antidiabetic medication to treat type 2 diabetes and for weight loss. Tirzepatide is administered via subcutaneous injections. It is sold in several countries under the brand name Mounjaro for diabetes treatment. In the United States it is sold with the trade name Zepbound for weight loss and treatment of obstructive sleep apnea.

Also known as...

LY3298176 and Zepbound

Wikipedia

Health Science World

Obesity drugs linked to stalling cancer

New research suggests popular weight-loss drugs may stall cancer progression by impacting metabolism.

How GLP-1s are more than just weight-loss wonders – but not without risk South China Morning Post — May 22, 23:15 PM
Eli Lilly’s next-gen obesity drug beats Ozempic and Mounjaro, helps patients lose over 30% body weight in trial The Indian Express — May 22, 05:17 AM
Lilly’s Mounjaro overtakes Keytruda as world’s top-selling drug Boston Globe — May 06, 22:58 PM
Eli Lilly is pouring an additional $4.5 billion into its Indiana manufacturing expansion Quartz — May 06, 14:10 PM
US prescription spending could top $1 trillion. GLP-1s lead the way USA Today — Apr 30, 21:47 PM
Bank signals interest rates could rise as Iran war to push up cost of living The Standard — Apr 30, 15:24 PM
Bailey: BOE Sees Inflation Little Over 3.5% by Year End Bloomberg — Apr 30, 12:11 PM
What the latest interest rates vote means for your mortgage, savings and bills The Independent — Apr 30, 12:03 PM
Bank of England holds interest rates at 3.75% but hints at future hikes The Argus — Apr 30, 11:33 AM
Eli Lilly will report first quarter earnings before the bell. Here's what Wall Street expects CNBC — Apr 30, 10:15 AM
Dr. Alok Patel breaks down Ebola concerns and new weight loss drug 📹 ABC News — May 22, 21:51 PM · 1min
Weight-loss drugs from Lilly, Novo linked to stalling cancer: report Seeking Alpha — May 22, 10:47 AM
New weight-loss drug Retatrutide showing stronger results than current options CBS News — May 21, 23:51 PM
Experimental drug yields dramatic weight loss Boston Globe — May 21, 20:32 PM
Lilly commits additional $4.5 billion in Indiana manufacturing sites - Reuters Reuters — May 06, 14:23 PM
Eli Lilly Kicks Off High-Grade Bond Sale in Push to Fund Deals Bloomberg — May 06, 12:40 PM
Bank of England faces the 'most difficult combination,' says governor Bailey as energy prices soar CNBC — Apr 30, 15:00 PM
Eli Lilly profits more than double as weight-loss drug sales soar Financial Times — Apr 30, 12:04 PM
AbbVie, Merck, Astra among winners of EU drug recommendations this week Seeking Alpha — May 22, 14:56 PM
Europe’s drugs regulator green-lights first oral weight-loss drug Politico EU — May 22, 12:29 PM